SAMUEL SHORES: Open Payments
NPI 1992477020 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 70 payments from 22 companies in 2025. Trend: 2023 $208 · 2024 $118 · 2025 $1,257
Food & beverage: $1,257
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 16 | $294 |
| Gilead Sciences, Inc. | 17 | $277 |
| ABBVIE INC. | 5 | $92 |
| PFIZER INC. | 4 | $75 |
| Amgen Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Astellas Pharma US Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Zimmer Biomet Holdings, Inc. | 1 | $31 |
Products named: DOVATO, CABENUVA, VRAYLAR, RUKOBIA, Veozah, MAVYRET, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across NC — which companies pay providers there.
